Please ensure Javascript is enabled for purposes of website accessibility

Foolish Forecast: Monsanto Still Growing

By Rich Smith – Updated Nov 15, 2016 at 5:43PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Views you can use to get clues on tomorrow's news.

Spring has sprung, and with it, the farmers are reporting earnings once again. Yesterday, we previewed the news due out from Delta & PineLand (NYSE:DLP). Today, we'll take a gander at Delta's sometimes-rival, other-times-licensor, and eternal counterparty in a lawsuit, Monsanto (NYSE:MON). The latter reports on its fiscal Q2 2006 numbers tomorrow before market-open.

What analysts say:

  • Buy, sell, or waffle? Ten analysts track Monsanto, but most of them do so from the fence. Only two venture forth with buy ratings; one more says "sell."
  • Revenues. The analysts expect to see sales grow 17% year over year to $2.2 billion.
  • Earnings. Profits should come in a bit lower, with projections calling for a 10% increase to $1.52 per share.

What management says:
In reviewing its fiscal Q1 2006 results back in January, Monsanto CEO Hugh Grant (no, the other one) commented as follows: "The contribution of our seeds and traits business continues to grow. . Stronger adoption of our traits in Australia, coupled with stronger and earlier sales of Roundup herbicides and the addition of the Seminis business, helped make this a record first quarter for our company. . [W]e believe we are on track for another strong fiscal year for our business."

What management does:
Although the winter quarter isn't exactly the strongest for agriculture, Monsanto's rolling numbers support Grant's assessment of the business. Over the past 18 months, the company has managed to grow its gross margins 60 basis points and to pass 40 of those all the way down to the bottom line.

Margins %

8/04

11/04

2/05

5/05

8/05

11/05

Gross

47.2

47.4

48.4

48.4

48.1

47.8

Op.

14.6

15.4

18.3

19.2

16.1

15.4

Net

4.9

5.9

9.2

5.4

4.1

5.3

All data courtesy of Capital IQ, a division of Standard & Poor's. Data reflects trailing-12-month performance for the quarters ending in the named months.

One Fool says:
So Monsanto has a strong past. The question for investors is whether it can sustain that strength in the future. In this regard, my fellow Fool Stephen Simpson, who reviewed the company's results last quarter, noted: "Monsanto has a very strong pipeline of products in grains and legumes (including traits for better herbicide tolerance and better drought resistance) and the opportunity to do a lot more in fruits and vegetables."

Combine the company's past success in the "stuff that grows" side of the business, its products due to come to market in the future, and the unarguable popularity of Monsanto's Roundup and similar "stuff that kills," and Monsanto does indeed seem well positioned.

Competitors:
In addition to Delta, which is as much a customer as a competitor, Monsanto's rivals include:

Fool contributorRich Smithdoes not own shares of any company named above.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DOW
Monsanto Company Stock Quote
Monsanto Company
MON

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.